These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4392344)

  • 21. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacologic profile of a new non-competitive antiadrenergic agent with an anti-angina potential--a derivative of amiodarone].
    Charlier R; Delaunois G; Bauthier J
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):234-52. PubMed ID: 4724571
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol.
    Kaplan HR; Barker JW; Dugan D; Fox J; Giardino E
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):28-43. PubMed ID: 4151048
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
    Alkondon M; Ray A; Sen P
    J Pharm Pharmacol; 1984 Oct; 36(10):702-4. PubMed ID: 6150094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 28. Trasicor: review of the pharmacology and clinical results.
    Fuccella LM
    S Afr Med J; 1969 Dec; ():Suppl:7-14. PubMed ID: 4190429
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of cardiac muscle of two drugs related to amiodarone, L8040 and L8462.
    Vaughan Williams EM; Polster P
    Eur J Pharmacol; 1974 Feb; 25(2):241-7. PubMed ID: 4435026
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46].
    Yoshida T; Takano M; Tamura A; Kubota H; Suzuki N
    Masui; 1970 May; 19(5):515-22. PubMed ID: 4393894
    [No Abstract]   [Full Text] [Related]  

  • 31. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiarrhythmic acitivity of pindolol in adrenaline-evoked ventricular arrhythmias in dogs anaesthetized with halothane in oxygen.
    Sharma PL
    Br J Anaesth; 1972 Dec; 44(12):1240-6. PubMed ID: 4650342
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 34. Arrhythmias in dogs associated with epinephrine and thiamylal anesthesia.
    Muir WW; Werner LL; Hamlin RL
    Am J Vet Res; 1975 Sep; 36(9):1291-7. PubMed ID: 51600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic effects of oxprenolol and practolol in dogs under halothane anaesthesia.
    Strong AJ; Macnicol MF; Davie IT; Scott DB
    Br J Anaesth; 1971 Jan; 43(1):25-32. PubMed ID: 4396678
    [No Abstract]   [Full Text] [Related]  

  • 36. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 37. Haemodynamic effects of beta-receptor blocking drugs during nitrous oxide-halothane anaesthesia.
    Stephen GW; Davie IT; Scott DB
    Br J Anaesth; 1971 Apr; 43(4):320-5. PubMed ID: 4396861
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of bretylium on experimental cardiac dysrhythmias.
    Allen JD; Zaidi SA; Shanks RG; Pantridge JF
    Am J Cardiol; 1972 May; 29(5):641-9. PubMed ID: 5021494
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of a beta-adrenergic blocking agent in myocardial infarct mortality].
    Lane JC; Rocha JC; dos Filho I; Frazatto C; Paladino S
    Arq Bras Cardiol; 1970 Feb; 23(1):45-8. PubMed ID: 5451898
    [No Abstract]   [Full Text] [Related]  

  • 40. The antiarrhythmic properties of BL-3677A.
    Buyniski JP; Gardier RW
    J Pharmacol Exp Ther; 1974 Aug; 190(2):289-99. PubMed ID: 4449041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.